Expert Forum on Multiple Myeloma - Dallas, TX

Expert Forum on Multiple Myeloma is organized by Oncology Meeting Innovations (OMI) and will be held from Aug 23 - 24, 2019 at Dallas, Texas, United States of America.

Key Topics:
• Review the current genomic landscape of multiple myeloma, clinical features of poor prognosis, mechanisms of resistance, immune signatures, and the integration of MRD into clinical trials
• Examine the evolving role of transplantation and cellular therapy for the treatment of multiple myeloma, including CAR-T, ASCT, and allogeneic SCT
• Evaluate key aspects of supportive care and complications, including bone disease, as well as definitions of disease, especially SMM/MGUS
• Debate proteasome inhibitors, how to tailor treatment to patient populations, and broader strategies to overcome proteasome inhibitor resistance
• Consider the benefits and challenges of long term lenalidomide therapy, as well as the emerging role of next-generation IMiDs and Cell Mods
• Discuss the integration of novel therapies and MoAbs in particular, including SLAMF7, CD 38, CAR-T cell therapy and targeting BCL2, as well as vaccines, and other novel targets, including nuclear export proteins and peptidase-avid alkylation
• Understand the continued potential of targeting BCMA both in the setting of CAR-T therapy and MoAbs/ADC’s

Additional details will be posted as soon as they are available.